Assessment of Biosimilarity in mAb-based Therapeutics Using SEC-MALS

Aplikace | 2025 | WatersInstrumentace
GPC/SEC
Zaměření
Farmaceutická analýza
Výrobce
Waters
PDF verze ke stažení a čtení
 

Podobná PDF

EC-MALS for absolute biophysical characterization
Multi-Attribute Quantitation of Antibody-Drug Conjugates by LC-MALS
Enhanced SEC-MALS analysis of therapeutic mAbs, biosimilars and AAVs with XBridge Premier columns
The Role of Multi-Angle Light Scattering in Biosimilar Characterization and Approval